Good MorningEquity markets started the week on shaky footing following a surprise attack by Hamas against Israel. The S&P 500 shed less than a full percent on the news and rebounded by the end of the session. The move suggests additional upside for the market this week, but there is risk. The CPI index is due out on Thursday and may show a surprise acceleration of inflation. Oil prices have corrected from their recent highs but remain well above 2023 average levels and will underpin inflation.
Oil was the big mover on Monday, gaining more than 4%. The advance shows support at the critical $85 price point and suggests that a rebound is underway. The move in oil is aided by violence in the Middle East. With tensions at historic highs, this conflict will certainly worsen before it improves and weigh heavily on the energy market.
The market also faces risk in the form of earnings. Friday starts peak earnings season and will bring reports from a half dozen US largest banks. Featured: Biden fires warning shot for retirement accounts... (GoldCo) 
|
Stocks | | |
The gig economy became mainstream through Uber Technologies Inc. (NYSE: UBER) and exploded during the COVID-19 pandemic. The lockdowns accelerated the evolution of remote work, the elastic office, and Zoom Video Communications Inc. (NASDAQ: ZM) calls. The combination created a perfect storm for th... Read the Full Story |
|
From Our Partners... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself. | | | | Click Here to Learn How >>> |
|
Markets | | |
Auto Worker Strike Dents Ford…Buying Opportunity
Just as U.S. auto manufacturers appeared well on the road to recovery, worker unrest is pumping the brakes. As Ford’s negotiations with the United Auto Workers (UAW) enter a third month, headlines around a possible prolonged stalemate ... Read the Full Story |
|
Healthcare | | |
Over the last month, the overall market has experienced significant selling amid increased uncertainty. The S&P 500 ETF Trust (NYSE: SPY) has traded almost 5.5% lower in that period, and wherever you look, it might seem that nothing has managed to buck the trend.
However, that’s n... Read the Full Story |
|
|
Stocks | | |
As part of this week's 'Ultimate Sale,' NIKE Inc. (NYSE: NKE) shoppers can save up to 60% on over 3,000 items. That's even better than the current 45% off sale on Nike shares.
On September 28, the athletic footwear and apparel leader reported 2024 fiscal first-quarter profits that were its ... Read the Full Story |
|
Markets | | | The world economy has lost momentum from the impact of higher interest rates, the invasion of Ukraine and widening geopolitical rifts, and it now faces new uncertainty from the war between Israel and Hamas militants, International Monetary Fund warned Tuesday.The IMF said it expects global economic ... Read the Full Story |
|
From Our PartnersDozens of 100% - 1,000% opportunities over the last decade have led to this one under-the-radar A.I. stock... | | | | More here. |
|
Stocks | | | Two Federal Reserve officials suggested Monday that the central bank may leave interest rates unchanged at its next meeting in three weeks because a surge in long-term interest rates has made borrowing more expensive and could help cool inflation without further action by the Fed. Since late July, t... Read the Full Story |
|
Markets | | |
Shares of Rivian (NASDAQ: RIVN) are down more than 20% following the announcement of a debt-offering and 30% from the 2023 high, providing the most attractive entry into this stock since early summer. There are reasons for the market to be down, but the move is overblown, amplified by short-sellin... Read the Full Story |
|
Markets | | | Chinese property developer Country Garden warned Tuesday that it cannot repay on time a 470 million Hong Kong dollar ($60 million) loan in the latest sign of distress after Beijing clamped down on mounting debts in the industry.The company said in a filing to the Hong Kong Stock Exchange that it “ex... Read the Full Story |
|
Markets | | | China is touting its 10-year-old Belt and Road Initiative as an alternative model for economic development, releasing a government report that praises the program while glossing over criticism that it has saddled poor countries with too much debt. The program championed by Chinese leader Xi Jinping ... Read the Full Story |
|
Markets | | | Price hikes lifted PepsiCo's profits in the third quarter, but the company says those increases are likely to moderate in the coming year.Pepsi raised prices 11% in the July-September period, the seventh straight quarter that the Purchase, New York, company has increased prices by double-digits. The... Read the Full Story |
|
Tuesday's Early Bird Stock Of The Day Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. | | View Today's Stock Pick |
|
